The BSA score in psoriasis patients with metabolic syndrome was 36.4 ± 22.3, in which patients with BSA classified as severe were 54.1%; the PASI score for psoriasis patients with metabolic syndrome was 25.2 ± 15.3, in which patients with PASI severity accounted for 48.2%.